Startseite » Members » Principal Investigator » Z1 » HoppeNils » Publications (selected)

Publications (selected)

2020

  • Erikainen S, Friesen P, Rand L, Jongsma K, Dunn M, Sorbie A, McCoy M, Bell J, Burgess M, Chen H, Chico V, Cunningham-Burley S, Darbyshire J, Dawson R, Evans A, Fahy N, Finlay T, Frith L, Goldenberg A, Hinton L, Hoppe N, Hughes N, Koenig B, Lignou S, McGowan M, Parker M, Prainsack B, Shabani M, Staunton C, Thompson R, Varnai K, Vayena E, Wiliams O, Williamson M, Chan S, Sheehan M. Public involvement in the governance of population-level biomedical research: unresolved questions and future directions. J Med Ethics. 2020 Oct 6:medethics-2020-106530. doi: 10.1136/medethics-2020-106530. Epub ahead of print. PMID: 33023977.
  • Lanzerath D, Illig T, Bernemann I, Hoppe N, Robienski J.  Humanbiobanken. Verlag Karl Alber, 2020, ISBN: 978-3-495-49037-2.

2019

  • Hermann L, Hoppe N, Kahrass H, Lohse S, Mertz M, Pietschmann I. How Ethics, Law and Philosophy of Science Can Help Make Progress in the Development and Use of Alternative Methods, In: ALTEX - Alternatives to Animal Experimentation, 36(4): 681

2018

  • Hoppe N. Die Widerspruchslösung in der Organspende: Warum eine alte Fragestellung ihre Aktualität nicht verliert. Transfusionsmedizin 8: 238-241.

  • Hoppe N. The Legal Governance of Animal Biotechnologies. In: Niemann H, Wrenzycki C (Eds.) Animal Biotechnology, in 2 volumes Springer International Publishing AG

2017

2016

2015

  • Briceño Moraia, L., Kaye, J., Tasse, A.M., Knoppers, B.M., Mitchell, C., Soini, S., Hoppe, N.C., Wallace, S.E., Øien, M. A comparative analysis of the requirements for the use of data in biobanks based in Finland, Germany, the Netherlands, Norway and the United Kingdom. Medical Law International. 14, 187-212.

2014

  • Hoppe, N.C., Miola, J. Medical Law and Medical Ethics. (Cambridge: Cambridge University Press)

  • Hoppe, N.C., Miola, J. Innovation in medicine through degeneration in law? A critical perspective on the Medical Innovation Bill. Medical Law International 14, 266-73.

  • Klose, J., Klose, M.A., Metz, C., Lehner, F., Manns, M.P., Klempnauer, J., Hoppe, N.C., Schrem, H., Kaltenborn, A. Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbecks Arch Surg 399, 1021-1029.

  • Lenk, C., Hoppe, N.C. Placebo-controlled trials: Is the EMA/ICH position consistent in itself and in accordance with the Declaration of Helsinki? Medical Law International 14, 115-132.

2013

  • Hoppe, N. The issue with tissue: why making human biomaterials available for research purposes is still controversial. Diag. Histopathology 19, 315-321.

  • Metz, C., Hoppe, N. Organ Transplantation in Germany: Regulating Scandals and Scandalous Regulation (Editorial). European Journal of Health Law 20, 113-116.

  • Hoppe, N. Innovative tissue engineering and its regulation. In: Flear, Mark; Hervey, Tamara; Murphy, Therese; Farrell, Anne-Maree, eds. European Law and New Health Technologies. (Oxford: Oxford University Press), 109-124.

2012

  • Kaye, J., Meslin, E.M., Knoppers, B.M., Juengst, E.T., Deschênes, M., Cambon-Thomsen, A., Chalmers, D., De Vries, J., Edwards, K., Hoppe N.C., et al. ELSI 2.0: A New International Collaboratory for Genomics and Society Research. Science 336, 673-674.

2011

  • Lenk, C., Hoppe, N.C., Beier, K., Wiesemann, C. (Eds.). Human Tissue Research – A European Perspective on the Ethical and Legal Challenges. (Oxford: Oxford University Press)